Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
57.3 USD | +0.33% |
|
+1.96% | +27.53% |
Jun. 28 | Barclays Raises Catalent's Price Target to $63 From $47, Maintains Equalweight Rating | MT |
Jun. 27 | Barclays Adjusts Catalent Price Target to $63 From $47 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.53% | 10.34B | |
+59.97% | 827B | |
+38.38% | 634B | |
-6.18% | 350B | |
+15.61% | 319B | |
+8.44% | 294B | |
+12.68% | 240B | |
+14.40% | 221B | |
+0.04% | 219B | |
+9.68% | 167B |
- Stock Market
- Equities
- CTLT Stock
- News Catalent, Inc.
- Transcript : Catalent, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 02